The steering committee of the Axis 2 "Genome Dynamics and Cancer" and its new coordinators (Eric Julien and Jean-Christophe Andrau) relaunch the face-to-face seminar of the Axis and invite you to meet them on September 15 and 16 in Toulouse. Free registration. Registration closes 02...
The seminar will be followed by a convivial moment with the staff of the BRIC unit
Anthony Bouter, UMR5248 CBMN, Bordeaux and Frédéric Saltel, U1312 BRIC, Bordeaux will speak at the Oncosphere's interdisciplinary seminars the 7 septembre at 12pm,conference room at IBGC and videoconference. Frédéric Saltel BRIC INSERM 1312, Team 03 - Liver Cancers and Tumor Invasion. Cancer cells transfer invasive...
For reasons of scientific data protection, the contents of internal seminars are not public. Unit members can view the program on the right side of our sharepoint homepage.
Alina Chan, Broad Institute of MIT & Harvard, will speak on July 4th at 4pm by videoconference. Invited by Andreas Bikfalvi, team leader of Team 01 - Tumor and vascular biology laboratory. "The Origines of COVID-19" Dr. Alina Chan is a co-author of the book,...
The NEWMOON Impulse Research Network, accredited by the University of Bordeaux at the beginning of the year, is organizing its kick-off on Thursday, June 30, from 1:30 to 6:00 p.m. in the Conference Room, CGFB, Campus Carreire. Many presentations from our researchers during this kick-off...
Sabine Colnot, Centre de Recherche des Cordeliers, Paris, will speak on June 28 at 3:00 pm, amphitheater 11, Carreire campus. Invited by Violaine Moreau, team leader of theTeam 03 - Liver Cancers and Tumor Invasion. "CRISPR-Cas9-engineered mice developing liver cancers with beta-catenin mutation: towards a...
For reasons of scientific data protection, the contents of internal seminars are not public. Unit members can view the program on the right side of our sharepoint homepage.
Thesis defense of Samuel Amintas, team 08 Biotherapies Genetics and Oncology BioGO. (S. Dabernat, F. Moreau-Gaudry) Title : Radiosensibilisation des tumeurs digestives par des molécules bioactives de l'alimentation. Jury: Mme JAVERZAT, Sophie, PR, Université de Bordeaux, Présidente Mme CARRIER, Alice, DR, Université d’Aix-Marseille, Rapporteure...
Andreas Bikfalvi, Head of Team 01 - Tumor and Vascular Biology Laboratory. "The notion of Truth in the Biomedical Sciences" The notion of truth has been debated extensively by philosophers and scientists alike for centuries. Relativist and absolutist/objectivist philosophies have a complete different understanding of...
Presentation organized by the BRIC technology group. pdf document to consult : CELLCYTE X Features & Benefits CYTENA - CELLCYTE X presentation - Full live cell imaging solution. Jim Engström, Field Application Specialist Julia Cantarini, Technical Sales Specialist - Live Cell Analysis - Central Europe...
Charles Dupin and Julian Boutin, Team 08 - Genetic Biotherapies and Oncology (BioGO) will be speaking on June 15 at 12:00 p.m. as part of Oncosphere's interdisciplinary seminars via videoconference. Video conferencing link. Charles Dupin, PH Radiothérapie potentialisée par un précurseur de l’hème dans...
Defense of the thesis of Pauline Michon, team 05 - Translational research in cutaneous oncology and rare skin diseases (TRIO2) (H. Rezvani, M. Beylot-Barry) Title: Profilage métabolique et immunitaire aux différents stades de la carcinogénèse cutanée. jeudi 9 juin à 13h30 dans l'amphi Louis...
In the context of the awarding of the title Honoris Causa to Michel L. Tremblay (Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada) by the University of Bordeaux (May 10 at 5:00 pm), Andreas Bikfalvi and the researchers of the unit are organizing a...
The first CRISPR and Translational Medicine Congress was held on March 31 and April 1st, 2022 in Bordeaux. CRISPR is one of the most powerful discoveries of the last decade and the scientific program of the congress is organized in six sessions dealing with major...
Aurélie Bedel, MCU-PH team 8 Biotherapies Genetics and Oncology has defended her HDR (Habilitation to Supervise Research) on the subject "Gene therapy: from effectiveness to safety". The challenge: the supervision of future theses!
